Medicine for improving bone quality based on nicotinamide and vitamin K2 and preparation method thereof

Abstract

The invention relates to the technical field of research and development of medicines and health-care products, in particular to a medicine for improving bone quality based on nicotinamide and vitamin K2 and a preparation method of the medicine. The medicine for improving bone quality based on nicotinamide and vitamin K2 comprises a composition containing nicotinamide and vitamin K2, and the active ingredients of the composition comprise nicotinamide (NAM), vitamin K2, vitamin D3, magnesium (Mg), calcium (Ca), zinc (Zn) and selenium (Se). The invention provides a medicine for improving bone quality based on nicotinamide and vitamin K2 and a preparation method of the medicine. The medicine is applied to medicines and / or health-care products for resisting senescence and preventing and treating osteoporosis and muscle spasm. The problem of combined application of NAD + precursor supplement-nicotinamide with an anti-aging function and a traditional anti-osteoporosis medicine is solved, the technical defects that an existing anti-aging product for preventing and treating osteoporosis and muscle spasm is slow in effect taking, insufficient in efficacy and incapable of achieving multiple effects at the same time are overcome, no harm is caused to a human body, and the product quality is stable.

Description

technical field [0001] The invention relates to the technical field of research and development of medicines and health care products, in particular to a medicine for improving bone quality based on nicotinamide and vitamin K2 and a preparation method thereof. Background technique [0002] Osteoporosis is a common chronic systemic disease among middle-aged and elderly people, characterized by decreased bone mass, destruction of bone microarchitecture, decreased bone quality, decreased bone strength, increased bone fragility, and susceptibility to fracture. The results of the China Osteoporosis Epidemiological Survey and the "Healthy Bones" Special Action Epidemiological Survey in July 2019 show that osteoporosis has become an important health problem for middle-aged and elderly people in my country, especially among middle-aged and elderly women. , the prevalence rate of people over 50 years old is 19.2%, and the prevalence rate of people over 65 years old reaches 32.0%. Stu...

AI Technical Summary

Problems solved by technology

In the prior art, anti-aging products do not take into account good effects of prevention and treatment of osteoporosis and muscle spasm, and products for prevention and treatment of osteoporosis and muscle spasm also do not take into account the effect of anti-aging. Stable new products with good anti-aging, prevention and treatment of osteoporosis and muscle spasm have become a problem to be solved urgently by those skilled in the art